HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ovarian malignant melanoma without evidence of teratoma.

Abstract
A 46-year-old woman with ovarian malignant melanoma had advanced intraperitoneal metastasis, retroperitoneal and inguinal lymph node metastases. Extensive debulking surgery was performed and chemotherapy was given. Microscopically, no evidence of other accompanying tumor, such as teratoma was noted. Detailed examination of the patient failed to identify any evidence of another primary melanoma site. It is assumed that spontaneous regression of the primary lesion occurred. Despite the surgery and chemotherapy, the patient died within 2 months of diagnosis. Considering this case, it is assumed that the combination of surgical debulking and chemotherapy are not always beneficial in ovarian malignant melanoma and the prognosis of ovarian malignant melanoma is very poor.
AuthorsSeung-Ho Lee, Kwang-Beom Lee, Jin-Woo Shin, Dong-Hae Chung, Chan-Yong Park
JournalThe journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 36 Issue 4 Pg. 898-901 (Aug 2010) ISSN: 1447-0756 [Electronic] Australia
PMID20666966 (Publication Type: Case Reports, Journal Article)
Topics
  • Fatal Outcome
  • Female
  • Humans
  • Melanoma (drug therapy, pathology, surgery)
  • Middle Aged
  • Ovarian Neoplasms (drug therapy, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: